Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of PET During Erlotinib Treatment to See the Responsiveness of Tumor Early in Patients With Non-small Cell Lung Cancer

NCT01000428 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT01000428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01000428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of PET During Erlotinib Treatment to See the Responsiveness of Tumor Early in Patients With Non-small Cell Lung Cancer
Lead sponsor
Asan Medical Center
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2009
Completion date
December 31, 2011
Enrollment
34 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erlotinib, lung cancer